| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |